Malaria News and Research

Latest Malaria News and Research

Canadian Statement to the World Health Assembly focuses on AIDS

The WHO's leadership is particularly important in the fight to combat HIV/AIDS. Last week, Canada bolstered its financial commitment to this effort with contributions of $100 million for WHO's '3 by 5 initiative', and $70 million to the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria. Canada and Canadians are proud to take these actions against HIV/AIDS.

19 May 2004

Discovery of the gene for Cornelia de Lange syndrome

An international team of researchers has discovered the gene for Cornelia de Lange syndrome, a disabling, multisystem genetic disease that affects an estimated one in 10,000 children. The finding is expected to lead to a genetic test, enabling rapid and definitive diagnosis of the syndrome, as well as prenatal testing for families who already have one child with the disease.

17 May 2004

International plan to rid the world of dirty dozen most toxic chemicals known to humankind

The 2001 Stockholm Convention on Persistent Organic Pollutants (POPs) enters into force on Monday, May 17, marking the start of an ambitious international effort to rid the world of PCBs, dioxins and furans, and nine highly dangerous pesticides.

17 May 2004

People with malaria who are too ill to take oral medication can benefit from rectal artesunate as initial treatment

People with moderate to severe malaria who are too ill to take oral medication can benefit from a single dose of rectal artesunate as initial treatment, conclude authors of a study in this week's issue of THE LANCET.

14 May 2004

Researchers identify new genes that control the formation of cilia found throughout the human body

Howard Hughes Medical Institute researchers have used a combination of brainpower and computer power to identify a multitude of new genes that control the formation of tiny, hair-like cilia that stipple the surfaces of many organs in a wide variety of creatures.

14 May 2004

WHO reports on treating tuberculosis in Ukraine

Multidrug-resistant TB (MDR-TB) is the disease caused by TB bacilli that are resistant to at least isoniazid and rifampicin – the two most powerful anti-TB drugs. It results from inconsistent or partial treatment of TB, and develops when public health programmes fail to deliver regular and reliable treatment to TB patients.

12 May 2004

Critical moment in the history of HIV/AIDS, more money, more political will, more deaths

This is a critical moment in the history of HIV/AIDS. There is more money, more political will and more attention being paid to this killer disease than ever before. And yet, more people than ever are dying of AIDS and becoming infected with HIV.

11 May 2004

Disease control strategies in Africa could help to halve deaths from malaria by 2010

Linking malaria programmes to other disease control strategies in Africa could help to halve deaths from malaria by 2010, say researchers in this week's BMJ.

6 May 2004

Study finds malaria drug does not affect the ability of airline crew to perform their duties

Results from a new study presented today at the 75th Annual Scientific Meeting of the Aerospace Medical Association (AsMA) in Anchorage, USA, suggest that MalaroneTM (atovaquone and proguanil hydrochloride) would not be expected to affect the ability of pilots and cabin crew to perform their duties while on an aircraft.

6 May 2004

Immtech signs agreement with CombinatoRx to test Immtech compounds as potential cancer treatment

Immtech International, Inc. announced today that it signed an agreement with CombinatoRx of Boston, Massachusetts to screen its lead aromatic cationic compounds, DB289 and DB75, for activity against various cancers.

5 May 2004

New technique of identifying genes may help researchers developing drugs

A quick new technique able to identify genes that evolve rapidly as well as those that change slowly already has pinpointed new targets for researchers developing drugs against tuberculosis and malaria, and it could do the same for other infectious diseases, according to a paper in this week's Nature.

29 Apr 2004

Canadian company requested to ship Dengue Fever test kits to Hong Kong immediately

Medical Services International Inc. has announced that it has been requested to ship VScan Dengue Fever test kits to Hong Kong immediately.

27 Apr 2004

Heart disease and stroke hit younger in developing countries

A new report to be released at Columbia University's Earth Institute on April 26, 2004, suggests that heart disease and stroke are far more urgent threats to global health than commonly appreciated. They are causing hundreds of thousands of deaths each year in young people of productive age.

26 Apr 2004

WHO calls for Sudan humanitarian assistance

Intensified and urgent action is needed in the Greater Darfur Region of western Sudan to address one of the most severe humanitarian emergencies today. Given the current situation, the humanitarian crisis will last several months.

23 Apr 2004

GSK and WHO collaborate to fight malaria

GlaxoSmithKline (GSK), the World Health Organisation's Special Programme for Research and Training in Tropical Diseases (WHO-TDR) and the Medicines for Malaria Venture (MMV) today announced the signing of a collaborative agreement, to develop a new-fixed dose artemisinin combination therapy drug (ACT), combining chlorproguanil, dapsone and artesunate (CDA) for the treatment of malaria.

23 Apr 2004

Access to effective malaria treatment for Africa threatened by drug shortages

Widespread use of a new fast-acting and potent treatment for malaria is finally on the horizon in Africa, where malaria is the number one killer of children.

22 Apr 2004

WHO renews call for effective malaria treatment

More than 600 million people, most of them children living in sub-Saharan Africa, face the daily threat of death from malaria because new, effective treatments are not available where they live. Existing, cheaper medicines, which have been used for many years, are no longer effective in most places because the malaria parasite has developed resistance to them.

22 Apr 2004

Malaria News and Research

Latest Malaria News and Research

Canadian Statement to the World Health Assembly focuses on AIDS

Discovery of the gene for Cornelia de Lange syndrome

International plan to rid the world of dirty dozen most toxic chemicals known to humankind

People with malaria who are too ill to take oral medication can benefit from rectal artesunate as initial treatment

Researchers identify new genes that control the formation of cilia found throughout the human body

WHO reports on treating tuberculosis in Ukraine

Critical moment in the history of HIV/AIDS, more money, more political will, more deaths

Disease control strategies in Africa could help to halve deaths from malaria by 2010

Study finds malaria drug does not affect the ability of airline crew to perform their duties

Immtech signs agreement with CombinatoRx to test Immtech compounds as potential cancer treatment

New technique of identifying genes may help researchers developing drugs

Canadian company requested to ship Dengue Fever test kits to Hong Kong immediately

Heart disease and stroke hit younger in developing countries

WHO calls for Sudan humanitarian assistance

GSK and WHO collaborate to fight malaria

Access to effective malaria treatment for Africa threatened by drug shortages

WHO renews call for effective malaria treatment

No relationship between HIV and oral polio vaccine

44 countries to hammer out global health issues at Earth Observation Summit

New forensic tool to detect infectious diseases

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in